Initiation of ARNi and SGLT2i in Patients With HFrEF

NCT05989503 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

62

Enrollment

OTHER

Sponsor class

Conditions

Heart Failure With Reduced Ejection Fraction

Interventions

DRUG: Sacubitril-valsartan
DRUG: SGLT2 inhibitor

Sponsor

Universidade do Porto

Collaborators

[object Object]
[object Object]